Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Is the Nail Psoriasis Severity Index reliable in the assessment of nail psoriasis by rheumatologists?

Lubrano E, Scrivo R, Cantini F, Marchesoni A, Mathieu A, Olivieri I, Salvarani C, Scarpa R, Spadaro A.

Arthritis Care Res (Hoboken). 2012 Mar;64(3):455-8. doi: 10.1002/acr.20691.

2.

Interobserver reliability of the Nail Psoriasis Severity Index.

Aktan S, Ilknur T, Akin C, Ozkan S.

Clin Exp Dermatol. 2007 Mar;32(2):141-4. Epub 2006 Nov 27.

PMID:
17137477
3.

The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis.

Cassell SE, Bieber JD, Rich P, Tutuncu ZN, Lee SJ, Kalunian KC, Wu CW, Kavanaugh A.

J Rheumatol. 2007 Jan;34(1):123-9.

4.

International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis.

Chandran V, Gottlieb A, Cook RJ, Duffin KC, Garg A, Helliwell P, Kavanaugh A, Krueger GG, Langley RG, Lynde C, McHugh N, Mease P, Olivieri I, Rahman P, Rosen CF, Salvarani C, Thaci D, Toloza SM, Wong MY, Zhou QM, Gladman DD.

Arthritis Rheum. 2009 Sep 15;61(9):1235-42. doi: 10.1002/art.24562.

5.

Fingernail psoriasis reconsidered: a case-control study.

van der Velden HM, Klaassen KM, van de Kerkhof PC, Pasch MC.

J Am Acad Dermatol. 2013 Aug;69(2):245-52. doi: 10.1016/j.jaad.2013.02.009. Epub 2013 Mar 28.

PMID:
23541759
6.

Extended report: nail disease in psoriatic arthritis--clinically important, potentially treatable and often overlooked.

Williamson L, Dalbeth N, Dockerty JL, Gee BC, Weatherall R, Wordsworth BP.

Rheumatology (Oxford). 2004 Jun;43(6):790-4. Epub 2004 Apr 27.

7.

Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis.

Rich P, Scher RK.

J Am Acad Dermatol. 2003 Aug;49(2):206-12.

PMID:
12894066
9.

Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study.

Rigopoulos D, Gregoriou S, Stratigos A, Larios G, Korfitis C, Papaioannou D, Antoniou C, Ioannides D.

Br J Dermatol. 2008 Aug;159(2):453-6. doi: 10.1111/j.1365-2133.2008.08686.x. Epub 2008 Jun 28.

PMID:
18565184
10.

Evaluation of nail disease in psoriatic arthritis by using a modified nail psoriasis severity score index.

Maejima H, Taniguchi T, Watarai A, Katsuoka K.

Int J Dermatol. 2010 Aug;49(8):901-6.

PMID:
21174373
11.

Impact of training on concordance among rheumatologists and dermatologists in the assessment of patients with psoriasis and psoriatic arthritis.

Salvarani C, Girolomoni G, Di Lernia V, Gisondi P, Tripepi G, Egan CG, Marchesoni A; DREAM study group.

Semin Arthritis Rheum. 2016 Jun 21. pii: S0049-0172(16)30074-9. doi: 10.1016/j.semarthrit.2016.06.004. [Epub ahead of print]

PMID:
27470190
12.

Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes.

Augustin M, Blome C, Costanzo A, Dauden E, Ferrandiz C, Girolomoni G, Gniadecki R, Iversen L, Menter A, Michaelis-Wittern K, Morita A, Nakagawa H, Reich K.

Br J Dermatol. 2014 Mar;170(3):591-8. doi: 10.1111/bjd.12664.

PMID:
24117393
13.

Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study.

Kavanaugh A, McInnes I, Mease P, Krueger GG, Gladman D, Gomez-Reino J, Papp K, Zrubek J, Mudivarthy S, Mack M, Visvanathan S, Beutler A.

Arthritis Rheum. 2009 Apr;60(4):976-86. doi: 10.1002/art.24403. Erratum in: Arthritis Rheum.2010 Aug;62(8):2555.

14.

Nail dystrophies, scalp and intergluteal/perianal psoriatic lesions: risk factors for psoriatic arthritis in mild skin psoriasis?

Patrizi A, Venturi M, Scorzoni R, Pazzaglia M, Malavolta N, Bardazzi F.

G Ital Dermatol Venereol. 2014 Apr;149(2):177-84.

PMID:
24819637
15.

Rheumatic manifestations of psoriasis.

Sadek HA, Abdel-Nasser AM, El-Amawy TA, Hassan SZ.

Clin Rheumatol. 2007 Apr;26(4):488-98. Epub 2006 May 3.

PMID:
16670829
16.

The comparison of Nail Psoriasis Severity Index with a less time-consuming qualitative system.

Kaçar N, Ergin S, Erdoğan BS.

J Eur Acad Dermatol Venereol. 2008 Feb;22(2):219-22. doi: 10.1111/j.1468-3083.2007.02389.x.

PMID:
18211416
17.

Prevalence and clinical patterns of psoriatic arthritis in Indian patients with psoriasis.

Kumar R, Sharma A, Dogra S.

Indian J Dermatol Venereol Leprol. 2014 Jan-Feb;80(1):15-23. doi: 10.4103/0378-6323.125472.

18.

Scoring nail psoriasis.

Klaassen KM, van de Kerkhof PC, Bastiaens MT, Plusjé LG, Baran RL, Pasch MC.

J Am Acad Dermatol. 2014 Jun;70(6):1061-6. doi: 10.1016/j.jaad.2014.02.010. Epub 2014 Mar 31.

PMID:
24698704
19.

Development of an assessment tool for dactylitis in patients with psoriatic arthritis.

Helliwell PS, Firth J, Ibrahim GH, Melsom RD, Shah I, Turner DE.

J Rheumatol. 2005 Sep;32(9):1745-50.

PMID:
16142872
20.

Evaluation of the efficacy of acitretin therapy for nail psoriasis.

Tosti A, Ricotti C, Romanelli P, Cameli N, Piraccini BM.

Arch Dermatol. 2009 Mar;145(3):269-71. doi: 10.1001/archdermatol.2008.600.

PMID:
19289755
Items per page

Supplemental Content

Write to the Help Desk